At Carnegie Imaging, women undergoing aneuploidy risk assessment (screening for Down Syndrome and other genetic conditions) have the option of Instant Risk Assessment (IRA), which allows women to receive their final results and counseling by one of our Maternal Fetal Medicine specialists on the day of their 11-13 week nuchal translucency ultrasound at Carnegie Imaging. With traditional aneuploidy screening, patients do not receive their results until a week later, generally from their referring provider’s office. In this 2010 publication in the American Journal of Perinatology, we demonstrated that women undergoing IRA had better understanding of aneuploidy screening, less anxiety, and more satisfaction than women who underwent traditional aneuploidy screening.
Maternal Fetal Medicine blogs are intended for educational purposes only and do not replace certified professional care. Medical conditions vary and change frequently. Please ask your doctor any questions you may have regarding your condition to receive a proper diagnosis or risk analysis. Thank you!